We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Ground-breaking new cancer treatments have moved a step closer with the signing of a major agreement between the government and BioNTech SE.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Population-based statistics on cancers treated with chemotherapy, radiotherapy and surgical tumour resection which were diagnosed between 2013 and 2016 in England.
Patients with a certain type of advanced or spreading non-small cell lung cancer (NSCLC) could access a new cancer therapy to help treat their condition.
Innovative researchers working to tackle some of the hardest-to-treat cancers, including through the use of AI, have received a £2 million funding boost.
Projects granted during 2014 that have a primary purpose of translational and applied research: human cancer.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Projects granted during 2015 that have a primary purpose of translational and applied research: projects on human cancer.
Overview of the UK's cancer research infrastructure and the advantages of investing in the UK's life science sector to develop new treatments.
For the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression
Projects granted during 2016 that have a primary purpose of translational and applied research - human cancer.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
Game-changing AI technology will be rolled out to all radiography departments in England in a matter of weeks – backed by £15.5 million in new Government funding.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).